Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al
- PMID: 31201171
- DOI: 10.1136/annrheumdis-2019-215615
Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al
Keywords: DMARDs (synthetic); systemic lupus erythematosus; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29. Ann Rheum Dis. 2019. PMID: 30926722
-
Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al.Ann Rheum Dis. 2020 Aug;79(8):e90. doi: 10.1136/annrheumdis-2019-215573. Epub 2019 May 2. Ann Rheum Dis. 2020. PMID: 31048291 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical